Abacus backs Mountaingate's acquisition of BioDerm

Abacus Finance Group LLC has provided $26.3 million in credit facilities to back Mountaingate Capital's buyout of BioDerm.

19 January 2021•3 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.